Angelina Jolie’s announcement of having a preventative double mastectomy has drawn attention to the test for BRCA1 and BRCA2, two genes that are associated with high breast cancer risk. An op-ed in The New York Times explains that some women are not able to get the test because it comes at...

An article in Bloomberg News reports “Two drugs from Bristol-Myers Squibb Co. (BMY) shrank tumors in as many as half of patients with advanced melanoma, according to early research that may pave the way for cocktails that trigger the immune system to destroy cancer.” A study found the amount of...

A new article in The New York Times, authored by famous actress Angelina Jolie, reveals that she had an 87% risk of breast cancer and 50% risk of ovarian cancer due to the BRCA1 gene, and she describes her decision to be proactive and minimize her risk by undergoing a preventive double mastectomy. While she...